PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis - Faetkenheuer, G.; Jessen, H.; Stoehr, A.; Jung, N.; Jessen, A. B.; Kuemmerle, T.; Berger, M.; Bogner, J. R.; Spinner, C. D.; Stephan, C.; Degen, O.; Vogelmann, R.; et al. (HIV Medicine, 2016)
Keywords: Adult; Anti-HIV Agents; Anti-HIV Agents - administration & dosage; Anti-HIV Agents - adverse effects; Darunavir; Darunavir - administration & dosage; Darunavir - adverse effects; ddc:no; Female; Germany; Human immunodeficiency virus; Humans; lopinavir; Male; occupational exposure; Post-Exposure Prophylaxis; Post-Exposure Prophylaxis - methods; Prospective Studies; Ritonavir; Ritonavir - administration & dosage; Ritonavir - adverse effects; sexual exposure; Treatment Outcome; Withholding Treatment; darunavir; lopinavir; sexual exposure; occupational exposure; post-exposure prophylaxis